Skip to main content
. 2022 Jul 1;13:812888. doi: 10.3389/fphar.2022.812888

TABLE 2.

Overview of the results of the 50% re-epithelialization level of the study wound.

EPO (n = 41) Placebo (n = 37) Total (n = 78)
50% re-ep*-level yes 40 (98%) 35 (95%) 75 (96%)
No (%) no 1 (2%) 2 (4%) 3 (4%)
Median (days) 10 10
Re-ep*-likelihood 98% 95% p = 0.802

*re-ep, re-epithelialization.